Mediphase Venture Partners is a venture capital firm in Newton that prefers to invest in life sciences and healthcare companies with a focus on biopharmaceutical technology and life sciences information. Founded in 1999 by Lawrence Miller and Paul Howard in Newton, Massachusetts, the firm invests in early stage ventures, late stage ventures, and private equity rounds. The notable investment portfolio of Mediphase Venture Partners includes Relypsa,Tetraphase Pharmaceuticals, Wellpartner, and Concert Pharmaceuticals. As of February 2020, Mediphase Venture Partners has made 21 investments. Their most recent investment was on Aug 14, 2012, when Relypsa raised $80M. Mediphase Venture Partners has had seven exits, the most notable of which include Relypsa, Concert Pharmaceuticals, and PatientKeeper.
Timeline
Funded Companies
A biopharmaceutical company developing drugs to treat cardiovascular and renal diseases
People
Amanda Cobb
Operations Manager
David C. Lubner
Financial Consultant
Lawrence G. Miller
Founding Partner
Paul A. Howard
Founding Partner
Further reading
Documentaries, videos and podcasts
Companies
Tetraphase Pharmaceuticals
Concert Pharmaceuticals
Relypsa
Wellpartner